Although t(4;11)(q21;q23) leading to a KMT2A–AFF1 fusion is a molecular marker of infant acute lymphoblastic leukemia (ALL), it can occur at any age, and is rarely also found in AML. Here, KMT2A is linked to acute lymphoblastic leukemia.